MEF2C and cancer: SLC39A14-mediated zinc acculation in muscle progenitor cells represses the expression of class I myosin and myocyte enhancer factor 2C and prevents muscle-cell differentiation and induces myosin heavy chain loss, which leads metastatic cancer promoting cachexia [43].